We provide you with 20 years of free, institutional-grade data for GTHX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GTHX. Explore the full financial landscape of GTHX stock.
| Reported Date | CIK | Ticker | Type |
|---|
G1 Therapeutics, Inc(NASDAQ:GTHX) 
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult ...
Website: http://www.g1therapeutics.com
Founded: 2008
Full Time Employees: 104
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about GTHX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.